Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Journal of Virology|December 16, 2011
Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularisElena Y Dobrikova, Christian Goetz, Robert W Walters, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2022
CD155 is a putative therapeutic target in medulloblastomaSean Li, Roger McLendon, Eric Sankey, et al.Journal for Immunotherapy of Cancer|April 20, 2021
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanomaGeorgia M Beasley, Smita K Nair, Norma E Farrow, et al.Nature Communications|March 26, 2021
Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signalingMichael C Brown, Mubeen M Mosaheb, Malte Mohme, et al.Cancer Research|January 21, 2018
XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer PhenotypeMyron K Evans, Michael C Brown, Joseph Geradts, et al.Cancer|June 19, 2014
Oncolytic polio virotherapy of cancerMichael C Brown, Elena Y Dobrikova, Mikhail I Dobrikov, et al.Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Lymphotropic Virotherapy Engages DC and High Endothelial Venule Inflammation to Mediate Cancer In Situ VaccinationAndrea L Ludwig, Zachary P McKay, Griffin P Carter, et al.Cancer Immunology Research|November 21, 2025
Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus AdministrationAndrea L Ludwig, Zachary P McKay, Griffin P Carter, et al.Journal for Immunotherapy of Cancer|September 29, 2022
Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanomaGeorgia M Beasley, Michael C Brown, Norma E Farrow, et al.The New England Journal of Medicine|June 27, 2018
Recurrent Glioblastoma Treated with Recombinant PoliovirusAnnick Desjardins, Matthias Gromeier, James E Herndon, et al.Pageof 9